Kai KupferschmidtScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.In June, Ravindra Gupta, a virologist at the University of Cambridge, heard of a cancer patient who had come into a local hospital the month before with COVID-19 and was still shedding virus.
The patient was being treated for a lymphoma that had relapsed and had been given rituximab, a drug that depletes antibody-producing B cells.